ZC3HC1 and neoplasm: Similarly, after having destructed the ZC3HC1 gene in several human cell lines by CRISPR/Cas9n technology, we did not note any generally obvious growth phenotype, in line with genome-scale CRISPR KO screens in human tumour cell lines [122].